– 1. Jiang H, Lin C, Cai T, et al.Taxifolin‐mediated Nrf2 activation ameliorates oxidative stress and apoptosis for the treatment of glucocorticoid‐induced osteonecrosis of the femoral head.Phytotherapy Research.2023
2. Tao M, Yan W, Chen C, et al.Omentin-1 ameliorates experimental inflammatory bowel disease via Nrf2 activation and redox regulation.Life Sciences.2023: 121847.
3. Jin B, Chen Y, Wang J, et al.Costunolide alleviates hyperglycaemia‐induced diabetic cardiomyopathy via inhibiting inflammatory responses and oxidative stress.Journal of Cellular and Molecular Medicine.2023
4. Zhang L, Hu C, Jin B, et al.Bicyclol Alleviates Streptozotocin-induced Diabetic Cardiomyopathy By Inhibiting Chronic Inflammation And Oxidative Stress.Cardiovascular Drugs and Therapy.2023: 1-14.
5. Lan J, Zhou Y, Wang H, et al.Protective Effect of Human Umbilical Cord Mesenchymal Stem Cell Derived Conditioned Medium in a Mutant TDP-43 Induced Motoneuron-Like Cellular Model of ALS.Brain Research Bulletin.2022
6. Fan P, Lu Y, Wei H, et al.Metformin attenuates sevoflurane-induced neurogenesis damage and cognitive impairment: involvement of the Nrf2/G6PD pathway.Metabolic Brain Disease.2023: 1-17.
7. Zheng W, Yang H, Lin H, et al.ML385 suppresses the proliferation, migration, and invasion of thyroid carcinoma cells by impairing aerobic glycolysis.Molecular & Cellular Toxicology.2023: 1-10.
8. Chen F, Zhu J, Wang W. Ulinastatin Attenuates LPS-Induced Inflammation and Inhibits Endoplasmic Reticulum Stress–Induced Apoptosis in Renal Tubular Epithelial Cells via Regulation of the TLR4/NF-κB and Nrf2/HO-1 Pathways. Inflammation. 2021: 1-10.
9. Liu Y, Hou M, Pan Z, et al. Arctiin-reinforced antioxidant microcarrier antagonizes osteoarthritis progression. Journal of Nanobiotechnology. 2022, 20(1): 1-20
10. Wu Y, Zeng S, Wan B, et al. Sophoricoside attenuates lipopolysaccharide-induced acute lung injury by activating the AMPK/Nrf2 signaling axis. International Immunopharmacology. 2021, 90: 107187
– Singh A, et al. Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors. ACS Chem Biol. 2016 Nov 18;11(11):3214-3225.
– Cc1sc(NC(=O)Cc2ccc3OCOc3c2)nc1-c1ccc2N(CCc2c1)C(=O)c1ccccc1C
– Apoptosis|||Immunology/Inflammation
Proudly representing
150+ years of combined research-supply heritage